Professor Ketan Dhatariya

Dr Catherine Gooday

Professor Ketan Dhatariya graduated from the University of London in 1991 and did his diabetes and endocrinology training in and around London. For 2 years during his training he was also a part time General Practitioner in the evenings. He took some time out of his training to spend a year doing intensive care medicine and anaesthetics. After he finished his diabetes training in 2001 he went to do a 2 year research fellowship in endocrinology at Mayo Clinic in Minnesota, USA. He was appointed as a consultant in diabetes, endocrinology and general medicine at the Norfolk & Norwich University Hospital in 2004, and Honorary Professor of Medicine at the University of East Anglia in 2019.  

He is a full time NHS clinician, with no dedicated research time or funding. His predominant areas of interest are inpatient diabetes – in particular peri-operative diabetes care, the management of diabetes related emergencies, and the ‘diabetic foot’. He leads one of the largest foot clinics in the East of England.

He has several national roles in the UK. He is currently the Chair of the Association of British Clinical Diabetologists and is also the immediate past chair of the Joint British Diabetes Societies Inpatient Care Group where he led or co-authored several national guidelines on the management of various aspects of inpatient diabetes care. He is the Chair of the Examining Board for the UK Specialist Clinical Exam in Diabetes and Endocrinology. He is also the immediate past President of the Diabetes and Endocrine section of the Royal Society of Medicine. He is the Section Co-editor for diabetes for www.endotext.org. He is an Associate Editor of Diabetic Medicine and, until 2023 was also an Associate Editor of BMJ Open Diabetes Research & Care.

Professor Dhatariya has over 190 peer reviewed publications, and has published over 20 book chapters on inpatient diabetes, peri-operative diabetes care or on the diabetic foot. He has been named as one of the world’s leading diabetes experts by www.expertscape.com

Dr Catherine Gooday graduated as a podiatrist from the University of Brighton, England. She has been the Principal Podiatrist within the Elsie Bertram Diabetes Centre, at the Norfolk and Norwich University Hospitals NHS Foundation Trust, England, since 2001.

In 2022, she completed her PhD funded by the National Institute for Health Research (NIHR) on defining the outcome measures of Charcot neuroarthropathy.

She is a member of the Offloading and Charcot neuro-osteoarthropathy working groups of the International Working Group on the Diabetic Foot (2023). She was also a member of the group that developed the NICE guidance; Diabetic foot problems: prevention and management (2015).

In 2023 she was appointed as Nursing, Midwifery, and AHP Research Lead, National Institute for Health and Care Research (NIHR), Clinical Research Network (CRN), East of England.
She now combines a clinical and academic career working to improve the outcomes for people with diabetic foot complications and support other Nurses, Midwifes, and AHPs to develop their research skills and career aspirations.  

Caroline Chen

Associate Professor Peter Lazzarini

Caroline is a senior pharmacist with the National Centre for Antimicrobial Stewardship, based at the Doherty Institute in Melbourne.

She has over 15 years’ experience in clinical infectious diseases and antimicrobial stewardship (AMS), and was one of the first AMS pharmacists in Australia where she established the service at the Royal Melbourne Hospital. She was also the co-founder of the National Antimicrobial Prescribing Survey (NAPS) program which now has over 2000 participating facilities across 14 countries and contributes to Australia’s antimicrobial usage surveillance program.

Her specific interests include AMS program delivery and the development, implementation and evaluation of digital solutions to enable AMS practice in health care facilities.

Associate Professor Pete Lazzarini is a podiatrist and Research Fellow with Queensland University of Technology and Queensland Health in Brisbane, Australia.

Pete has an internationally-recognised track record in diabetes foot disease research, with >110 peer-reviewed publications and >$5.8 million in grant funding in the field. He is the Secretary of the International Working Group on the Diabetic Foot Offloading Guideline Group, was Founding Chair of Diabetes Feet Australia and has held National Health and Medical Research Council Fellowships.

Pete leads a diabetes foot disease research program that has produced significant new global knowledge: quantifying disease burdens, identifying risk factors and developing novel treatments. He is particularly motivated by nurturing the next generation of researchers to develop practice and policy solutions that help end avoidable amputations within a generation.